{
  "trial_id": "NCT01633853",
  "trial_group": "chronic kidney disease",
  "generated-by-gpt4-omni-zs": {
    "gen-response": "Age, gender, stage of chronic kidney disease, baseline blood levels of calcium, baseline blood levels of phosphorus, baseline blood levels of intact parathyroid hormone, history of chronic kidney disease mineral and bone disorder, concurrent medications, history of liver failure, history of intestinal malabsorption or chronic diarrhea, history of fractures, presence of renal artery stenosis, presence of inherent renal malformation, presence of solitary kidney, presence of malignancy in urinary system, presence of active systemic immunity diseases, history of primary hyperparathyroidism, anticipated dialysis, hospitalization history within 30 days before screening, life expectancy, current enrollment in other investigational studies, current treatment with vitamin D 50,000 IU, use of glucocorticoid or immunosuppressive agents, presence of acute renal dysfunction, pregnancy or lactation status, history of acute myocardial infarction, history of acute congestive heart failure, history of stroke, geographical residence.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "gender"
        ],
        [
          "Ca-baseline",
          "baseline blood levels of calcium"
        ],
        [
          "P-baseline",
          "baseline blood levels of phosphorus"
        ],
        [
          "iPTH-baseline",
          "baseline blood levels of intact parathyroid hormone"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment",
        "25(OH)Vit D"
      ],
      "remaining_candidate_features": [
        "stage of chronic kidney disease",
        "history of chronic kidney disease mineral and bone disorder",
        "concurrent medications",
        "history of liver failure",
        "history of intestinal malabsorption or chronic diarrhea",
        "history of fractures",
        "presence of renal artery stenosis",
        "presence of inherent renal malformation",
        "presence of solitary kidney",
        "presence of malignancy in urinary system",
        "presence of active systemic immunity diseases",
        "history of primary hyperparathyroidism",
        "anticipated dialysis",
        "hospitalization history within 30 days before screening",
        "life expectancy",
        "current enrollment in other investigational studies",
        "current treatment with vitamin D 50",
        "000 IU",
        "use of glucocorticoid or immunosuppressive agents",
        "presence of acute renal dysfunction",
        "pregnancy or lactation status",
        "history of acute myocardial infarction",
        "history of acute congestive heart failure",
        "history of stroke",
        "geographical residence."
      ]
    },
    "processed-gen-response": "Age, gender, stage of chronic kidney disease, baseline blood levels of calcium, baseline blood levels of phosphorus, baseline blood levels of intact parathyroid hormone, history of chronic kidney disease mineral and bone disorder, concurrent medications, history of liver failure, history of intestinal malabsorption or chronic diarrhea, history of fractures, presence of renal artery stenosis, presence of inherent renal malformation, presence of solitary kidney, presence of malignancy in urinary system, presence of active systemic immunity diseases, history of primary hyperparathyroidism, anticipated dialysis, hospitalization history within 30 days before screening, life expectancy, current enrollment in other investigational studies, current treatment with vitamin D 50, 000 IU, use of glucocorticoid or immunosuppressive agents, presence of acute renal dysfunction, pregnancy or lactation status, history of acute myocardial infarction, history of acute congestive heart failure, history of stroke, geographical residence."
  },
  "generated-by-gpt4-omni-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Chronic Kidney Disease Stage, Baseline Serum Calcium, Baseline Serum Phosphorus, Baseline Intact Parathyroid Hormone, History of Fractures, History of Liver Disease, History of Intestinal Malabsorption, Use of Medications Affecting Vitamin D Metabolism, ",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Ca-baseline",
          "Baseline Serum Calcium"
        ],
        [
          "P-baseline",
          "Baseline Serum Phosphorus"
        ],
        [
          "iPTH-baseline",
          "Baseline Intact Parathyroid Hormone"
        ]
      ],
      "remaining_reference_features": [
        "25(OH)Vit D"
      ],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Chronic Kidney Disease Stage",
        "History of Fractures",
        "History of Liver Disease",
        "History of Intestinal Malabsorption",
        "Use of Medications Affecting Vitamin D Metabolism"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Chronic Kidney Disease Stage, Baseline Serum Calcium, Baseline Serum Phosphorus, Baseline Intact Parathyroid Hormone, History of Fractures, History of Liver Disease, History of Intestinal Malabsorption, Use of Medications Affecting Vitamin D Metabolism"
  },
  "generated-by-llama3-70b-in-ts": {
    "gen-response": "Age, Continuous, Sex: Female, Male, Race/Ethnicity, Customized, Region of Enrollment, Estimated Glomerular Filtration Rate (eGFR), Serum Calcium, Serum Phosphorus, Intact Parathyroid Hormone (iPTH), 25-Hydroxyvitamin D, Vitamin D Deficiency Status, Chronic Kidney Disease Stage,",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "Sex: Female"
        ],
        [
          "Male",
          "Male"
        ],
        [
          "Region of Enrollment",
          "Region of Enrollment"
        ],
        [
          "Ca-baseline",
          "Serum Calcium"
        ],
        [
          "P-baseline",
          "Serum Phosphorus"
        ],
        [
          "iPTH-baseline",
          "Intact Parathyroid Hormone (iPTH)"
        ],
        [
          "25(OH)Vit D",
          "25-Hydroxyvitamin D"
        ]
      ],
      "remaining_reference_features": [],
      "remaining_candidate_features": [
        "Race/Ethnicity",
        "Estimated Glomerular Filtration Rate (eGFR)",
        "Vitamin D Deficiency Status",
        "Chronic Kidney Disease Stage"
      ]
    },
    "processed-gen-response": "Age, Sex: Female, Male, Race/Ethnicity, Region of Enrollment, Estimated Glomerular Filtration Rate (eGFR), Serum Calcium, Serum Phosphorus, Intact Parathyroid Hormone (iPTH), 25-Hydroxyvitamin D, Vitamin D Deficiency Status, Chronic Kidney Disease Stage"
  },
  "generated-by-llama3-70b-in-zs": {
    "gen-response": "Age, sex, race, body mass index (BMI), chronic kidney disease stage, duration of chronic kidney disease, history of diabetes, history of hypertension, history of cardiovascular disease, smoking status, serum creatinine, estimated glomerular filtration rate (eGFR), albumin, hemoglobin, serum calcium, serum phosphorus, intact parathyroid hormone (iPTH), 25-hydroxyvitamin D, vitamin D deficiency status.",
    "evaluated-by-gpt4-omni": {
      "matched_features": [
        [
          "Age",
          "Age"
        ],
        [
          "Sex: Female",
          "sex"
        ],
        [
          "Ca-baseline",
          "serum calcium"
        ],
        [
          "P-baseline",
          "serum phosphorus"
        ],
        [
          "iPTH-baseline",
          "intact parathyroid hormone (iPTH)"
        ],
        [
          "25(OH)Vit D",
          "25-hydroxyvitamin D"
        ]
      ],
      "remaining_reference_features": [
        "Male",
        "Region of Enrollment"
      ],
      "remaining_candidate_features": [
        "race",
        "body mass index (BMI)",
        "chronic kidney disease stage",
        "duration of chronic kidney disease",
        "history of diabetes",
        "history of hypertension",
        "history of cardiovascular disease",
        "smoking status",
        "serum creatinine",
        "estimated glomerular filtration rate (eGFR)",
        "albumin",
        "hemoglobin",
        "vitamin D deficiency status."
      ]
    },
    "processed-gen-response": "Age, sex, race, body mass index (BMI), chronic kidney disease stage, duration of chronic kidney disease, history of diabetes, history of hypertension, history of cardiovascular disease, smoking status, serum creatinine, estimated glomerular filtration rate (eGFR), albumin, hemoglobin, serum calcium, serum phosphorus, intact parathyroid hormone (iPTH), 25-hydroxyvitamin D, vitamin D deficiency status."
  }
}